NCT07398326 2026-02-09Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal CancerShanghai Changzheng HospitalPhase 2 Recruiting37 enrolled
NCT05229003 2024-07-03Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRCFudan UniversityPhase 2 Recruiting44 enrolled